Myocardial Infarction (MI)RACARNCT07399379
Augmented Reality as Discharge Information for Hospitalized Cardiology Patients
A study testing Augmented reality app in people with Myocardial Infarction (MI) and Pacemaker Implantation, run by Hospital Universitario Getafe at 1 site in Spain.
Trial summary
The goal of this clinical trial is to find out whether a simple augmented reality tool provided at hospital discharge can improve patients' understanding of their care, adherence to treatment, and health outcomes, compared with the usual discharge information. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Myocardial Infarction (MI), Pacemaker Implantation, Heart Failure
- What is being tested?
- Augmented reality app
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 303 participants
- Where
- 1 siteSpain
- Study dates
- 23 Feb 2024to 29 Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Participants must have access to a mobile device (such as a smartphone or tablet).
- Participants must have been admitted to the Cardiology Department of Getafe University Hospital for ischemic heart disease, heart failure, atrial fibrillation, or pacemaker implantation.
Who cannot join
- No access to a mobile device.
- Untreated visual or hearing impairments that prevent viewing or understanding the videos.
- Inability to understand Spanish
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Implementation of an Augmented Reality System to Complement Discharge Information in Hospitalized Cardiology Patients
The goal of this clinical trial is to find out whether a simple augmented reality tool provided at hospital discharge can improve patients' understanding of their care, adherence to treatment, and health outcomes, compared with the usual discharge information.
This study includes adult patients who are admitted to a cardiology department because of:
Read more
- Ischaemic heart disease
- Atrial fibrillation
- Heart failure
- Or who need a pacemaker implantation
The main questions this study aims to answer are:
- Does providing augmented reality information at discharge improve patients' perceived quality of care?
- Does it improve patients' adherence to their prescribed treatment?
- Does it reduce major cardiovascular events such as hospital readmission, heart attack, stroke, or cardiovascular death?
Researchers will compare two groups of participants:
- A control group, who will receive the usual medical discharge report.
- An intervention group, who will receive the usual medical discharge report plus an information card with a drawing and a QR code that gives access to an augmented reality application.
Participants will:
- Receive their discharge information according to the group they are assigned to.
- Use the augmented reality application if they are in the intervention group.
- Be followed over time to assess treatment adherence, patient experience, and cardiovascular events.
This is a low-intervention, randomized, single-centre clinical trial conducted in Getafe, Madrid, Spain. Participation in this study does not involve taking any additional medication.
- Conditions
- Myocardial Infarction (MI), Pacemaker Implantation, Heart Failure, Atrial Fibrillation (AF)
- Being tested
- Augmented reality app
- Keywords
- Augmented reality, Acute Coronary Syndrome, Heart Failure, Pacemaker, PREM, Atrial Fibrillation
- Medical subject headings
- Myocardial Infarction, Heart Failure, Atrial Fibrillation, Acute Coronary Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Augmented reality appDevice
The card provided in addition to the usual medical discharge report is designed with a simple drawing that identifies each condition and a QR code.
This code can be scanned from any mobile device using the device's camera. Once scanned, a 3D model of a heart or a stent (depending on the condition) appears on the device, showing movement, vibration, and sound as an example of augmented reality.
The user can also access simple options through three buttons:
- Video recorded by a cardiology professional: a brief and easy-to-understand explanation of the patient's condition, lasting approximately 2-3 minutes, provided by a hospital cardiology professional.
- Treatment recommendations: a drop-down section with a table of discharge recommendations for the patient's condition, including lifestyle and dietary advice.
- Warning signs: situations that the patient should pay attention to and seek medical advice if they occur.
| Study group | Role | What they receive |
|---|---|---|
| Intervention Group | Active comparator | This group receives the usual medical discharge report plus an information card with a drawing and a QR code that gives access to an augmented reality application explaining their disease. Receives: Device: Augmented reality app |
| Control group | No intervention | This group receives the usual medical discharge report. |
What is being measured
The primary outcome is the main question the study is designed to answer.
PRIMARY OUTCOME: PREM and treatment adherence at one and six months
To assess PREM (Patient-Reported Experience Measures) in the intervention group and in the control group at discharge and at follow-up.
Measured: Follow up at one and six months from enrollment
Secondary outcomes (1)
MACE at one and six months
Data on major adverse cardiovascular events (MACE) will also be collected at one and six months from discharge in both groups. MACE include heart attack, stroke, cardiovascular-related hospital readmission, and cardiovascular death.
Measured: From enrollment at one and six months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Feb 2026
- Study start23 Feb 2024
- Primary completion16 Dec 2025
- Study completion29 Dec 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for Myocardial Infarction (MI)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 303 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hospital Universitario Getafe
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07399379
- Sponsor's protocol ID
- CEIm 23/44
- Other IDs
- SEC/FEC-INV-CLI 23/12
- Acronym
- RACAR
- Status last verified
- Feb 2026
- First submitted
- 13 Jan 2026
- Last updated
- 10 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual Participant Data will not be shared because the dataset contains sensitive patient health information, including medical history and follow-up outcomes. Sharing these data could risk patient confidentiality. All data will be handled according to current data protection regulations and only anonymized, aggregated results will be made publicly available.
Publications
Davies F. Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Quarterly. 1989; 13: 319-40.
Lahanas V, Loukas C, Smailis N, Georgiou E. A novel augmented reality simulator for skills assessment in minimal invasive surgery. Surg Endosc. 2015 Aug;29(8):2224-34. doi: 10.1007/s00464-014-3930-y. Epub 2014 Oct 11.
PubMed 25303925Kang X, Azizian M, Wilson E, Wu K, Martin AD, Kane TD, Peters CA, Cleary K, Shekhar R. Stereoscopic augmented reality for laparoscopic surgery. Surg Endosc. 2014 Jul;28(7):2227-35. doi: 10.1007/s00464-014-3433-x. Epub 2014 Feb 1.
PubMed 24488352Barroso Osuna, J., & Cabero Almenara, J. (2016). Evaluación de objetos de aprendizaje en Realidad Aumentada: estudio piloto en el grado de Medicina. Enseñanza & Teaching: Revista Interuniversitaria De Didáctica, 34(2), 149-67. https://doi.org/10.14201/et2016342149167.
Almenara, J.C., Osuna, J.B., Puente, Á.P., et al. Realidad Aumentada para aumentar la formación en la enseñanza de la Medicina. Educ. Medica. Super. 2018; 32 (4): 1-14.
Study at a glance
From the registry record, last updated by the sponsor on 10 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Implementation of an Augmented Reality System to Complement Discharge Information in Hospitalized Cardiology Patients
- ClinicalTrials.gov ID
- NCT07399379
- Acronym / sponsor ID
- RACAR / CEIm 23/44
- Conditions
- Myocardial Infarction (MI), Pacemaker Implantation, Heart Failure, Atrial Fibrillation (AF)
- Keywords
- Augmented reality, Acute Coronary Syndrome, Heart Failure, Pacemaker, PREM, Atrial Fibrillation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 303 participants (actual)
- Lead sponsor
- Hospital Universitario GetafeUniversity, hospital or other
- Study start
- 23 Feb 2024 (actual)
- Primary completion
- 16 Dec 2025 (actual)
- Study completion
- 29 Dec 2025 (actual)
- First posted
- 10 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to find out whether a simple augmented reality tool provided at hospital discharge can improve patients' understanding of their care, adherence to treatment, and health outcomes, compared with the usual discharge information.
This study includes adult patients who are admitted to a cardiology department because of:
- Ischaemic heart disease
- Atrial fibrillation
- Heart failure
- Or who need a pacemaker implantation
The main questions this study aims to answer are:
- Does providing augmented reality information at discharge improve patients' perceived quality of care?
- Does it improve patients' adherence to their prescribed treatment?
- Does it reduce major cardiovascular events such as hospital readmission, heart attack, stroke, or cardiovascular death?
Researchers will compare two groups of participants:
- A control group, who will receive the usual medical discharge report.
- An intervention group, who will receive the usual medical discharge report plus an information card with a drawing and a QR code that gives access to an augmented reality application.
Participants will:
- Receive their discharge information according to the group they are assigned to.
- Use the augmented reality application if they are in the intervention group.
- Be followed over time to assess treatment adherence, patient experience, and cardiovascular events.
This is a low-intervention, randomized, single-centre clinical trial conducted in Getafe, Madrid, Spain. Participation in this study does not involve taking any additional medication.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention Group | Active comparator | Device: Augmented reality appThis group receives the usual medical discharge report plus an information card with a drawing and a QR code that gives access to an augmented reality application explaining their disease. |
| Control group | No intervention | –This group receives the usual medical discharge report. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Participants must have access to a mobile device (such as a smartphone or tablet).
- Participants must have been admitted to the Cardiology Department of Getafe University Hospital for ischemic heart disease, heart failure, atrial fibrillation, or pacemaker implantation.
Key exclusion criteria (3 listed)
- No access to a mobile device.
- Untreated visual or hearing impairments that prevent viewing or understanding the videos.
- Inability to understand Spanish
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Augmented reality appThe card provided in addition to the usual medical discharge report is designed with a simple drawing that identifies each condition and a QR code. This code can be scanned from any mobile device using the device's camera. Once scanned, a 3D model of a heart or a stent (depending on the condition) appears on the device, showing movement, vibration, and sound as an example of augmented reality. The user can also access simple options through three buttons: 1. Video recorded by a cardiology professional: a brief and easy-to-understand explanation of the patient's condition, lasting approximately 2-3 minutes, provided by a hospital cardiology professional. 2. Treatment recommendations: a drop-down section with a table of discharge recommendations for the patient's condition, including lifestyle and dietary advice. 3. Warning signs: situations that the patient should pay attention to and seek medical advice if they occur. | Device | Intervention Group |
Primary outcome
PRIMARY OUTCOME: PREM and treatment adherence at one and six months
Time frame: Follow up at one and six months from enrollment
To assess PREM (Patient-Reported Experience Measures) in the intervention group and in the control group at discharge and at follow-up.
1 secondary outcome
MACE at one and six months
Time frame: From enrollment at one and six months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Feb 2026.
- BackgroundDavies F. Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Quarterly. 1989; 13: 319-40.
- Background: PubMed 25303925Lahanas V, Loukas C, Smailis N, Georgiou E. A novel augmented reality simulator for skills assessment in minimal invasive surgery. Surg Endosc. 2015 Aug;29(8):2224-34. doi: 10.1007/s00464-014-3930-y. Epub 2014 Oct 11.
- Background: PubMed 24488352Kang X, Azizian M, Wilson E, Wu K, Martin AD, Kane TD, Peters CA, Cleary K, Shekhar R. Stereoscopic augmented reality for laparoscopic surgery. Surg Endosc. 2014 Jul;28(7):2227-35. doi: 10.1007/s00464-014-3433-x. Epub 2014 Feb 1.
- BackgroundBarroso Osuna, J., & Cabero Almenara, J. (2016). Evaluación de objetos de aprendizaje en Realidad Aumentada: estudio piloto en el grado de Medicina. Enseñanza & Teaching: Revista Interuniversitaria De Didáctica, 34(2), 149-67. https://doi.org/10.14201/et2016342149167.
- BackgroundAlmenara, J.C., Osuna, J.B., Puente, Á.P., et al. Realidad Aumentada para aumentar la formación en la enseñanza de la Medicina. Educ. Medica. Super. 2018; 32 (4): 1-14.
- Individual participant dataSharing planned: No. Individual Participant Data will not be shared because the dataset contains sensitive patient health information, including medical history and follow-up outcomes. Sharing these data could risk patient confidentiality. All data will be handled according to current data protection regulations and only anonymized, aggregated results will be made publicly available.
Related trials for Myocardial Infarction (MI)
RecruitingPhase 2
Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction
Myocardial Infarction, Reperfusion Injury
Recruiting
ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathY
Myocardial Infarction (MI), Sudden Cardiac Death Due to Cardiac Arrhythmia
RecruitingObservational study
Breisgau PHENO-HEART MI
Myocardial Infarction, STEMI
Not yet recruiting
Pilot Study to Determine the Optimal Protocol for Preoperative Transcutaneous Vagal Neurostimulation
Atrial Fibrillation (AF), Cerebral Vascular Accident (CVA)
Recruiting
Optimal Timing of Staged Complete Revascularization in STEMI With Multivessel Disease (OPTION-STEMI2)
Myocardial Infarction (MI)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Augmented reality app in people with Myocardial Infarction (MI) and Pacemaker Implantation, run by Hospital Universitario Getafe at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
PRIMARY OUTCOME: PREM and treatment adherence at one and six months (time frame: Follow up at one and six months from enrollment). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07399379, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Feb 2026.